We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Viatris Selling Its Biosimilars Business to Bangalore-Based Biocon for Up to $3.3B
Viatris Selling Its Biosimilars Business to Bangalore-Based Biocon for Up to $3.3B
A biologics-focused subsidiary of Bangalore, India-based Biocon is buying the biosimilars portfolio of Pittsburgh, Pa.-based Viatris for up to $3.3 billion.